Kaytee Bio is a biotech company that research and develop new drugs and diagnostic technologies.



Topics

 

 Sep.1st, 2017 (NEW!!)

Japanese Organization for Medical Device Development, Inc (https://jomdd.com) has begun to launch the Talin Test as RUO in U.S.

 

 Apr. 1st, 2017

Our patents of Talin Test have been registered in UK, France, Germany, and Italy. 

 Jul. 21st, 2016

We have presented our latest multi-center research about BiologicMate® for the efficacy of infliximab in  2016 EULAR Congress Meeting in  London (June 8-11th, 2016). Details Here!

 

Mar. 25th, 2016

Kaytee Bio, Co.&Ltd. was posted on the April issue of Nature’s MedTech Dealmakers which have a journalistic feature on diagnostics.

Mar. 14th, 2016

Kaytee Bio,Co.&Ltd. concluded the License Contracts on the distribution and R&D of our technology regarding  BiologicMate® and Talin Test exclusively in the countries including U.S.A. with Japanese Organization for Medical Device Development, Inc (https://jomdd.com). 

 

 Dec. 18th, 2014

We have presented our latest findings about BiologicMate® in 2014 ACR/ARHP Annual Scientific Meeting (Nov 15th-19th) in Boston.

Kaytee Bio Co.&Ltd.

 

<Headquarter    

                  &Laboratory>

   Room #505,

   Yamaguchi Bdg,      

   Funabashi,

   4-38-22,  Honcho,                      

   Funabashi,

   Chiba 273-0005, JAPAN

   TEL: +81474110017

   FAX: +81474110018

 

 

Case Reports of Talin Test

▶️Multi-center trial for the efficacy of infliximab